Ucb Sa Unspadr Stock Net Income
| UNC0 Stock | EUR 125.00 3.00 2.46% |
As of the 5th of March, UCB SA owns the Mean Deviation of 1.39, standard deviation of 2.08, and Market Risk Adjusted Performance of 0.7016. Compared to fundamental indicators, the technical analysis model makes it possible for you to check helpful technical drivers of UCB SA UNSPADR, as well as the relationship between them. Please validate UCB SA UNSPADR coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if UCB SA UNSPADR is priced fairly, providing market reflects its prevailing price of 125.0 per share.
UCB SA Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 47.5 B | Enterprise Value Revenue 7.0516 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 958.5 M | 576.8 M | |
| Net Income | 958.5 M | 576.8 M |
UCB | Net Income |
The Net Income trend for UCB SA UNSPADR offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether UCB SA is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest UCB SA's Net Income Growth Pattern
Below is the plot of the Net Income of UCB SA UNSPADR over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in UCB SA UNSPADR financial statement analysis. It represents the amount of money remaining after all of UCB SA UNSPADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is UCB SA's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in UCB SA's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 887 M | 10 Years Trend |
|
Net Income |
| Timeline |
UCB Net Income Regression Statistics
| Arithmetic Mean | 944,547,059 | |
| Geometric Mean | 899,773,624 | |
| Coefficient Of Variation | 25.71 | |
| Mean Deviation | 175,981,315 | |
| Median | 1,058,000,000 | |
| Standard Deviation | 242,836,236 | |
| Sample Variance | 58969.4T | |
| Range | 722M | |
| R-Value | (0.54) | |
| Mean Square Error | 44405.6T | |
| R-Squared | 0.29 | |
| Significance | 0.02 | |
| Slope | (26,076,225) | |
| Total Sum of Squares | 943511T |
UCB Net Income History
UCB SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to UCB SA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of UCB SA.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in UCB SA on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding UCB SA UNSPADR or generate 0.0% return on investment in UCB SA over 90 days. UCB SA is related to or competes with China Construction, PT Bank, NVIDIA CORP, APPLE INC, and AMAZON INCCDR. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases More
UCB SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure UCB SA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess UCB SA UNSPADR upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.11 | |||
| Information Ratio | 0.0371 | |||
| Maximum Drawdown | 14.46 | |||
| Value At Risk | (2.84) | |||
| Potential Upside | 3.03 |
UCB SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as UCB SA's standard deviation. In reality, there are many statistical measures that can use UCB SA historical prices to predict the future UCB SA's volatility.| Risk Adjusted Performance | 0.0502 | |||
| Jensen Alpha | 0.106 | |||
| Total Risk Alpha | 0.0168 | |||
| Sortino Ratio | 0.0367 | |||
| Treynor Ratio | 0.6916 |
UCB SA March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0502 | |||
| Market Risk Adjusted Performance | 0.7016 | |||
| Mean Deviation | 1.39 | |||
| Semi Deviation | 1.52 | |||
| Downside Deviation | 2.11 | |||
| Coefficient Of Variation | 1715.93 | |||
| Standard Deviation | 2.08 | |||
| Variance | 4.35 | |||
| Information Ratio | 0.0371 | |||
| Jensen Alpha | 0.106 | |||
| Total Risk Alpha | 0.0168 | |||
| Sortino Ratio | 0.0367 | |||
| Treynor Ratio | 0.6916 | |||
| Maximum Drawdown | 14.46 | |||
| Value At Risk | (2.84) | |||
| Potential Upside | 3.03 | |||
| Downside Variance | 4.45 | |||
| Semi Variance | 2.3 | |||
| Expected Short fall | (2.30) | |||
| Skewness | 0.6158 | |||
| Kurtosis | 3.8 |
UCB SA UNSPADR Backtested Returns
UCB SA UNSPADR retains Efficiency (Sharpe Ratio) of close to zero, which indicates the company had a close to zero % return per unit of volatility over the last 3 months. UCB SA exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate UCB SA's Standard Deviation of 2.08, market risk adjusted performance of 0.7016, and Mean Deviation of 1.39 to confirm the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.16, which indicates not very significant fluctuations relative to the market. As returns on the market increase, UCB SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding UCB SA is expected to be smaller as well. At this point, UCB SA UNSPADR has a negative expected return of -0.0068%. Please make sure to validate UCB SA's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if UCB SA UNSPADR performance from the past will be repeated in the future.
Auto-correlation | 0.68 |
Good predictability
UCB SA UNSPADR has good predictability. Overlapping area represents the amount of predictability between UCB SA time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of UCB SA UNSPADR price movement. The serial correlation of 0.68 indicates that around 68.0% of current UCB SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.68 | |
| Spearman Rank Test | 0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 22.84 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
UCB Net Interest Income
Net Interest Income |
|
Based on the recorded statements, UCB SA UNSPADR reported net income of 887 M. This is 159.9% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net income for all Germany stocks is 55.35% lower than that of the firm.
UCB Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses UCB SA's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of UCB SA could also be used in its relative valuation, which is a method of valuing UCB SA by comparing valuation metrics of similar companies.UCB SA is currently under evaluation in net income category among its peers.
UCB Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.07 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 48.29 B | ||||
| Shares Outstanding | 379.99 M | ||||
| Price To Earning | 16.09 X | ||||
| Price To Book | 4.79 X | ||||
| Price To Sales | 6.14 X | ||||
| Revenue | 7.74 B | ||||
| Gross Profit | 5.75 B | ||||
| EBITDA | 2.61 B | ||||
| Net Income | 887 M | ||||
| Cash And Equivalents | 515 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 2 M | ||||
| Debt To Equity | 0.34 % | ||||
| Current Ratio | 1.12 X | ||||
| Book Value Per Share | 57.09 X | ||||
| Cash Flow From Operations | 1.46 B | ||||
| Earnings Per Share | 3.43 X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Number Of Employees | 9.77 K | ||||
| Beta | 0.26 | ||||
| Market Capitalization | 47.5 B | ||||
| Total Asset | 17.35 B | ||||
| Retained Earnings | 7.39 B | ||||
| Working Capital | 1.26 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 17.35 B | ||||
| Last Dividend Paid | 1.45 |
About UCB SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze UCB SA UNSPADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of UCB SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of UCB SA UNSPADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in UCB Stock
UCB SA financial ratios help investors to determine whether UCB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.